MAIER; Sabine

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAIER; Sabine.The latest application filed is for "methods of treating tumor".

Company Profile

3.9.21

MAIER; Sabine - Lawrenceville NJ
Maier; Sabine - Brussels N/A BE
Maier; Sabine - Princeton NJ US
Maier; Sabine - Berlin DE
Maier, Sabine - Heidelberg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Tumor App 20210380693 - MAIER; Sabine ; et al.	2021-12-09
Methods Of Treating Tumor App 20210101980 - BHAGAVATHEESWARAN; Prabhu Seshaiyer ; et al.	2021-04-08
Methods Of Treating Tumor App 20210032344 - Bhagavatheeswaran; Prabhu Seshaiyer ; et al.	2021-02-04
Methods Of Treating Tumor App 20200239577 - BHAGAVATHEESWARAN; Prabhu Seshaiyer ; et al.	2020-07-30
Markers for the prediction of outcome of anthracycline treatment Grant 10,053,735 - Foekens , et al. August 21, 2	2018-08-21
Method and nucleic acids for the analysis of colon cell proliferative disorders Grant 9,988,683 - Adorjan , et al. June 5, 2	2018-06-05
Method And Nucleic Acids For The Analysis Of A Colon Cell Proliferative Disorder App 20150275312 - Adorjan; Peter ; et al.	2015-10-01
Methods for the prognosis of breast cancer Grant 9,017,944 - Foekens , et al. April 28, 2	2015-04-28
Method and Nucleic Acids for the Analysis of Colorectal Cell Proliferative Disorders App 20140179563 - Adorjan; Peter ; et al.	2014-06-26
Method and nucleic acids for the analysis of colorectal cell proliferative disorders Grant 8,691,503 - Adorjan , et al. April 8, 2	2014-04-08
Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative Disorders App 20120184455 - Foekens; John ; et al.	2012-07-19
Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy Grant 8,101,359 - Foekens , et al. January 24, 2	2012-01-24
Method And Nucleic Acids For The Analysis Of Colon Cell Proliferative Disorders App 20110046005 - ADORJAN; PETER ; et al.	2011-02-24
Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients App 20090269736 - Nimmrich; Inko ; et al.	2009-10-29
Markers For The Prediction Of Outcome Of Anthracycline Treatment App 20090111707 - Foekens; John ; et al.	2009-04-30
Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative Disorders App 20080254447 - Foekens; John ; et al.	2008-10-16
Epigenetic Methods and Nucleic Acids for the Detection of Lung Cell Proliferative Disorders App 20080171318 - Plum; Achim ; et al.	2008-07-17
Method and nucleic acids for the analysis of a lung cell proliferative disorder App 20070128592 - Burger; Matthias ; et al.	2007-06-07
Method and nucleic acids for the analysis of breast cell proliferative disorders App 20060292564 - Maier; Sabine	2006-12-28
Method and nucleic acids for the analysis of a colon cell proliferative disorder App 20060246433 - Adorjan; Peter ; et al.	2006-11-02
Method and nucleic acids for the analysis of colon cell proliferative disorders App 20060234224 - Adorjan; Peter ; et al.	2006-10-19
Method and nucleic acids for the improved treatment of breast cell proliferative disorders App 20060121467 - Foekens; John ; et al.	2006-06-08
Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients App 20060024684 - Foekens; John ; et al.	2006-02-02
Method and nucleic acids for the analysis of colorectal cell proliferative disorders App 20050003463 - Adorjan, Peter ; et al.	2005-01-06
Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders App 20040234973 - Adorjan, Peter ; et al.	2004-11-25
Low affinity screening method App 20040082079 - Besenbruch, Ralf ; et al.	2004-04-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.